“Analysis of the Effectiveness of the Combination of Bevacizumab and Irinotecan for the Treatment of Glial Tumors”. Research, Society and Development, vol. 11, no. 1, Jan. 2022, p. e37911125135, https://doi.org/10.33448/rsd-v11i1.25135.